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1. Introduction 
Dialysis services are expensive. Typically, a country spends 1 to 2% of its healthcare budget 
treating less than 0.1% of its population that requires dialysis (De Vecchi et al, 1999). In 
western countries, 90% of the patients are treated with haemodialysis in a dialysis centre 
attached or affiliated to a hospital.  
The literature shows that when given the choice, up to 50% of dialysis patients will prefer to 
perform the procedure at home (Jager et al, 2004, Goovaerts et al, 2005) . Performing dialysis 
at home can generate significant cost savings to high income country healthcare systems and 
societies while improving survival, reducing morbidity (i.e., dialysis-related complications, 
hospital acquired infection, etc.) and increasing patient’s quality of life. Furthermore, 
patients’ satisfaction with care is higher with home modalities (Fadem SZ, 2011). Home 
dialysis therefore represents an opportunity for healthcare systems to improve health gains 
in their population while reducing the cost per case of a dialysis patient. 
In a survey of 6595 nephrology healthcare professionals, 56% mentioned home/self-care 
modalities as the preferred long-term dialysis modalities (Ledebo & Ronco, 2008). Yet, in 
western countries only 10% of the patients are treated at home with either peritoneal 
dialysis or home haemodialysis. Canada, the Netherlands, the UK and the Scandinavian 
countries have a much higher (20-30%) usage of home modalities. 
Reimbursement and organization of renal care have often been cited as being responsible for 
the differences observed between countries. This chapter will review the organization and 
financing of dialysis in 14 countries and suggests a 4-pillar framework to explain the 
differences observed between countries. Correcting or addressing each of these 4 pillars will 
be essential for home modalities such as peritoneal dialysis to benefit a significant number 
of patients in a country. This chapter will propose a few avenues for this. 
2. The framework 
A 4-pillar framework (Figure 1) was postulated as an explanation of the extent to which 
home dialysis modalities are used. The 4 pillars can be described as follows: 
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Pillar 1 – Home target: the presence of a peritoneal dialysis or home dialysis target, i.e., a 
specific proportion of dialysis patients that should be treated at home, ideally within a 
specified time frame.  
Pillar 2 - Organization of renal services:  with a particular focus on the absence of undesired 
financial imbalance favouring one modality over the other (i.e., provider-driven demand 
rather than based on patient’s needs), the availability of a well-structured pre-dialysis 
education program for stage 4 patients, the availability of home assistance for elderly 
patients, and the presence of a renal replacement therapy career or “home first” 
guideline/policy.  
Pillar 3 – Incentives: either financially or quality-based for home dialysis.  
Pillar 4 – Tracking: a renal registry or some other form of tracking system to monitor dialysis 
quality and/or clinical outcomes such as survival, hospitalizations, complications, etc. and 
to plan future dialysis needs. 
 
 
Fig. 1. Framework for renal policy and reimbursement 
3. The analysis 
Publicly available information on the organization of dialysis care in 14 target countries was 
reviewed and scored using a semi-quantitative scoring algorithm based on the 4-pillar 
framework (Table 1). The relationship between the score and the percent of patients 
performing dialysis at home (as per the latest information available, i.e., 2008 data from the 
European Renal Association-European Dialysis and Transplant Association renal registry, 
the United States Renal Data System, the Canadian Organ Replacement Register, the MNC 
Medical Netcare report for Germany and a publication by Gloor, 2010 for Switzerland) was 
explored with a regression analysis. An analysis of variance was performed to identify 
which factors of the 4-pillar framework were more associated with a higher usage of home 
modalities. The evolution of home dialysis usage during the a 5-year period (2004 to 2008) in 
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countries where the data was available was plotted on a graph to identify trends and try to 
relate them to changes in the respective local healthcare system. 
 
Pillar Score Description 
1  Home target +1 per 15% target 
2  Organization of renal 
services 
  
     Provider-driven demand -2 Provider “profit” largely favouring in-centre 
modalities 
-1 Important in-centre haemodialysis over capacity or 
tariffs too low to cover all costs 
0 No significant provider profit imbalance between 
modalities 
     Pre-dialysis education -1 Presence of information bias due to prescriber 
being also provider of dialysis services 
0 No well organized pre-dialysis education 
+1 Pre-dialysis education in usage in most of the 
centres. Could be secured in a guideline or other 
official document. 
     Assisted dialysis -1 Significant hurdles to supply and/or finance 
0 Per case basis 
+1 Official tariff 
     Payment flow -1 Payment for home modalities via a different 
channel than in-centre modalities 
+1 Payment for all modalities going through hospital 
     RRT career/home   
     guideline/policy 
0 Absence of guideline/policy recommending home 
modalities 
+1 Presence of a guideline or other official 
recommendation/document favouring home 
modalities 
3  Incentive 0 No incentive for home modalities 
+1 Presence of an incentive (e.g., key performance 
indicator, bonus scheme) favouring home 
4  Tracking 0 No registry or other means of tracking the 
epidemiology and survival of dialysis patients 
+1 Existence of a registry recording/reporting 
incidence and prevalence with or without survival 
+2 Existence of a registry recording/reporting in 
addition some intermediate quality indicators with 
or without recommendations for changes 
+3 Existence of a registry recording/reporting final 
quality indicators such as evolution of survival 
with time, infections and hospitalizations rates 
Table 1. Scoring criteria 
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4. Results 
4.1 Pillar 1 - Home target 
Some countries (Figure 2) have set a target for dialysis patients to be treated at home. This 
target is either for peritoneal dialysis as in Norway (30%), for home haemodialysis as in the 
UK (10-15%) or for home dialysis (i.e., peritoneal dialysis and home haemodialysis) as in 
Denmark (45%). The issuing body could be a government body or a government-appointed 
committee like in the UK or Denmark or an independent group of experts like Sweden or 
the nephrologist association like in Finland. In only a few instances (Austria, Denmark, 
Stockholm County) was this target accompanied by a timeline. Evidence of an 
implementation plan could not be found in any of the countries surveyed, except maybe in 
Ontario, one of the Canadian provinces (Provincial Peritoneal Dialysis Coordinating 
Committee, 2006). 
  
 
Fig. 2. Home targets 
4.2 Pillar 2 – organization of renal services 
Except for the USA, all countries have a public healthcare system. However, even in the 
USA, most dialysis patients are covered under the public system, Medicare (Mendelssohn 
DC, 2009). Dialysis providers are financed through either an overall department budget 
(e.g., Finland, some parts of Austria) or via a retrospective fee-for-service or prospective 
payment system like disease related groups. Transport costs and expensive medications 
such as erythropoietin stimulating agents or phosphate binders are paid through a different 
channel, increasing the difficulty for an exact comparison of costs between in-centre and 
home modalities. Medical monitoring is most of the time included within the tariff. In-centre 
haemodialysis has often the highest tariff and chronic ambulatory peritoneal dialysis the 
lowest. In some countries like Italy, the tariffs are more than 10 years old. In others like in 
the UK, France and the Nordic countries, a good tracking system of costs is in place and 
tariffs are updated on a yearly basis. In France, Austria, Denmark and Switzerland the 
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payment for home modalities is made via a different channel than in-centre modalities, 
therefore not contributing to the revenues of the dialysis centre where the prescriber of 
dialysis sits. 
Healthcare tariffs are commonly set as closely as possible to the real costs. This is done in 
order to avoid creating an imbalance in “profitability” between services that would lead to 
an increased usage of one service over the others based on the “profits” it generates to the 
provider rather than based on the benefits it can bring to patients. In healthcare financing, 
this is called provider-driven demand. Most healthcare system would track healthcare costs 
(i.e., using paid tariffs) per type of provider, but provider costs are not publicly available. 
Therefore, the real costs of dialysis were not available for most countries and we could not 
estimate if there was a major difference in provider’s “profit” between home and in-centre 
modalities. However, based on the most recent analysis performed in Belgium (Cleemput et 
al, 2010) where automated peritoneal dialysis with more biocompatible and/or non glucose-
based solutions is used in about 60% of the peritoneal dialysis patients, it can be seen that 
peritoneal dialysis costs to a dialysis provider (i.e., excluding transport and medications in 
the case of Belgium) are slightly lower than in-centre haemodialysis and in the same range 
as limited-care haemodialysis (Figure 3).  
 
 
Fig. 3. 2006 costs of PD and HD to Belgium dialysis providers (Cleemput et al, 2010) 
Therefore, the peritoneal dialysis and in-centre haemodialysis tariffs should not be too wide 
apart, otherwise it is likely to create a disproportionate “profit” in favour of in-centre 
haemodialysis. A large difference in tariffs in favour of in-centre modalities was found in 
most countries. In the USA, however, the recent changes in the tariffs are creating the 
reverse effect, i.e., disproportionate profit in favour of peritoneal dialysis. This was done on 
purpose, recognizing the overall lower healthcare costs associated with peritoneal dialysis 
(Berger et al, 2009; Cleemput et al, 2010; Figure 4) and changing the tariff setting method 
from cost-based to value-based. 
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Fig. 4. 2006 Belgian total healthcare costs for dialysis patients (excluding transport; n=7230; 
Cleemput et al, 2010) 
Well structured pre-dialysis education programs (where chronic kidney disease stage 4 
patients are walked through the complications of the disease, the various renal replacement 
therapy modalities and the prevention measures to be taken to delay further decline in their 
renal function) exist mainly in Nordic countries. The USA has just implemented its new 
chronic kidney disease education program in 2010 and they are the only country so far with 
a payment attached to it (Medicare, 2010; Young et al, 2011). 
Nursing assistance at home is available in some countries, but sometimes the financing is 
obscure and it is left to the nephrologist to organize. 
Although most countries have some kind of guidelines on haemodialysis, peritoneal 
dialysis, or the management of anaemia, etc., none of them have a holistic guideline that 
sees end stage renal disease patients as cycling between various renal replacement therapies, 
therefore requiring focusing on the “big picture” rather than on each decision point 
separately (Braun Curtin et al, 2003).  Finland, however, has a “home first” approach. It was 
originally developed by the Helsinki hospital (Honkanen & Rauta, 2008) but is followed 
throughout the country and is further supported by the nephrologist and patient 
associations’ quality of renal care criteria (Kidney and Transplant Patients Association, 
2006). The British National Institute for Health and Clinical Excellence is currently preparing 
a clinical guideline for peritoneal dialysis. The draft that has been circulated for consultation 
(National Institute for Health and Clinical Excellence, 2011) mentioned the need to have 
patient-centred care where the patients’ needs and preferences are taken into account and 
where patients are enabled to make informed decisions on their options. The draft guidance 
also refers to the renal replacement therapy career concept. How this guideline will be 
implemented remains unclear at this moment. 
4.3 Pillar 3 – incentives 
In 2001, Belgium implemented a bonus scheme to favour the treatment of patients outside of 
the hospital premises (Royal Decree, 2006), and although PD benefited from it at the 
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beginning, limited care HD was the great winner of this bonus scheme. The USA is currently 
starting its Quality Incentive Program focusing on indicators such as anaemia and urea 
reduction ratio (Medicare, 2011). This is in fact a penalty scheme where payment is reduced 
by up to 2% if the dialysis provider fails to reach the quality standards. The UK has also 
recently published its quality standards for chronic kidney disease, but no intention to link 
them to payment has been announced yet (National Institute for Health and Clinical 
Excellence, 2010). In the Netherlands, the Hans Mak Institute is qualifying dialysis centres 
(including an on-site inspection and a patients’ survey every 3 years); the standards as well 
as the results of the qualification are publicly available for patients to consult on their 
website (Hans Mak Institute, 2011).  
4.4 Pillar 4 – tracking 
Renal registries exist in many countries. The data recorded are often only limited to the 
number of incident and prevalent patients as well as mortality. Morbidity indicators such as 
infections or hospitalizations are rarely recorded. Registries are not often used for planning 
purposes. 
4.5 Scores 
Scores varied from -2 in Germany to +5 in Denmark, Sweden, Canada and Netherlands.  All 
Nordic countries scored 4 or 5. The total score of each country is displayed in Figure 5 and a 
detailed description of the scoring results is given in Table 2. 
 
 
Fig. 5. 4-pillar framework total score 
www.intechopen.com
 Progress in Peritoneal Dialysis 
 
122 
 
Table 2. Continued 
(c
o
rr
ec
te
d
 
in
 2
01
1)
 
D
o
cu
m
en
te
d
 
www.intechopen.com
A Renal Policy and Financing Framework to Understand  
Which Factors Favour Home Treatments Such as Peritoneal Dialysis 
 
123 
 
Table 2. Continued 
www.intechopen.com
 Progress in Peritoneal Dialysis 
 
124 
 
Table 2. Continued 
www.intechopen.com
A Renal Policy and Financing Framework to Understand  
Which Factors Favour Home Treatments Such as Peritoneal Dialysis 
 
125 
 
Table 2. Scoring 
m
o
d
al
it
ie
s 
d
es
p
it
e 
b
et
te
r 
www.intechopen.com
 Progress in Peritoneal Dialysis 
 
126 
5. Analysis 
5.1 Regression analysis 
The regression analysis reveals a significant (p<0.001) correlation between the total score 
and the use of home dialysis. In countries like Denmark or Sweden where the score was 5, 
26-27 % of their dialysis patients are treated at home. At the opposite end of the spectrum, 
Germany, which obtained a score of -2 is using home dialysis in only 4.2% of its dialysis 
population (Figure 5). 
 
 
r2=0.694; p<0.001. AU: Austria; BE: Belgium; CAN: Canada; CH: Switzerland; DK: Denmark; F: France; 
FI: Finland; G: Germany; I: Italy; NL: the Netherlands; NO: Norway; S: Sweden; UK: United Kingdom; 
USA: United States of America 
Fig. 6. Correlation between framework score and percent use of home dialysis 
5.2 Analysis of variance 
The analysis of variance showed that 3 factors were significantly predictive of home usage. 
These were pre-dialysis education (p<0.001), clinical guidelines/policies favouring home 
modalities (p=0.002) and (the absence of) provider-driven demand (p=0.035).  
5.3 Time trends 
The usage of home modalities over the 2004-2008 period was plotted on a graph to identify 
trends (Figure 6). Three different trends were observed. Small (3-5%) upward trends were 
observed in Denmark, Finland, Sweden and Canada, countries that already have a large 
proportion of their dialysis patients at home. A larger upward trend was observed in 
Austria (14%), but as the home usage was small to start with, this increase does not result in 
a significant absolute increase in home usage. The second trend was observed in countries 
like Belgium the USA, and Germany. These countries have a low usage of home modalities 
and there is no indication that this is changing. The third trend is seen in the Netherlands 
and in the UK, where home dialysis usage has markedly dropped over the 2004-2008 period, 
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from 27.7% to 22.4% in the Netherlands and from 25.9% to 19.1% in the UK, a 19% drop in 
the Netherlands and a 26% drop in the UK. It is interesting to note that these two countries 
implemented healthcare reforms during that time that had an overall objective of increasing 
competition among providers (that led to the opening of private dialysis centres) in the hope 
of decreasing healthcare costs. 
 
 
 
 
 
 
Fig. 7. Evolution of home dialysis usage over the 2004-2008 period 
6. The recommendations 
The 14 systems analyzed provide a series of possible avenues for change in local renal policy 
and reimbursement in order to create an environment that promotes home therapies such as 
peritoneal dialysis.  
6.1 Pillar 1 – home target 
Considering that 70% of patients are eligible for peritoneal dialysis and that when offered, 
50% of them would choose peritoneal dialysis (Jager et al, 2004), a 35% target for peritoneal 
dialysis appears reasonable. For home haemodialysis, the literature cites approximately 10-
15%. Therefore, ultimately, the goal should be to have around 45-50% of patients treated at 
home (35% peritoneal dialysis, 10-15% home haemodialysis). This target should be 
accompanied with an implementation plan to ensure better results. This implementation 
plan has been lacking in most countries that have such a target so far. 
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Recommendation 1: Set a reasonable proportion of patients (e.g., 10 to 15% over the current 
level up to 35% for peritoneal dialysis and 15% home haemodialysis) that should be treated 
at home within a set time frame (e.g., 5 years). 
6.2 Pillar 2 – organization of renal services 
The financing of dialysis in most countries with a high usage of home modalities is 
characterized by limited financial imbalance between modalities so that provider-driven 
demand (i.e., when the demand for a service is based on the benefits to the provider rather 
than the benefits to the patient) is avoided. This was a significant factor in the analysis of 
variance. Furthermore, in these countries, all payments are made via the same entity, i.e., the 
dialysis clinic.  
Recommendation 2: Correct provider-driven demand by adjusting reimbursement levels to 
real costs or healthcare system value and use similar payment flow for in-centre and home 
modalities. Make healthcare costs more transparent by tracking provider costs and making 
them available to public. 
Pre-dialysis education is well structured and organized in most countries with a high usage 
of home modalities. As mentioned earlier, when patients are informed of the various 
modalities, 50% of them will choose a home based therapy. The proportion is only slightly 
lower (35%) in the case of unplanned urgent start (Rioux et al, 2011). Pre-dialysis education, 
if performed in an unbiased way, should lead to a large increase in the use of home 
modalities. This factor was also significant in the analysis of variance. 
Recommendation 3: Drive the development of high quality, unbiased, and ideally 
independent pre-dialysis education programs by providing adequate reimbursement for 
this activity. 
Assisted dialysis is seldom available but is seen as a means to support home treatment.  
Assistance is not recommended for all patients but should be available for patients in some 
situations.  For example, it can be useful while being trained for peritoneal dialysis or home 
haemodialysis; for patients who have had an urgent and unplanned start on dialysis to 
enable them to be discharged home before training starts; for patients or carers approaching 
burnout; for frail elderly patients who may not be able to manage all of their dialysis 
themselves; or for patients with particular mobility or dexterity problems who require 
assistance to enable dialysis at home. 
Recommendation 4: Facilitate and actively encourage the adoption of home dialysis 
through the provision and reimbursement of assisted home dialysis. 
Guidelines/policies on home dialysis were found in all countries with a high usage of home 
modalities. This was a significant factor in the analysis of variance. 
Recommendation 5: Establish a holistic approach of dialysis care in an overall dialysis care 
guideline/policy integrating the patient “renal replacement therapy career” or “home first” 
concepts. 
6.3 Pillar 3 - incentive 
The Belgian financial incentive was effective in moving patients from in-centre 
haemodialysis to modalities where patients take more responsibility for their own therapy. 
This is the only example of a financial incentive available at the country level in the 14-
country sample. The Italian incentive is only available in two provinces, while in Austria the 
incentive is the lack of resources rather than a financial incentive. These may not be 
sufficient to counteract the payment flow issue in Austria and the provider-driven demand 
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in both countries. However, limited care haemodialysis performed in a hospital 
environment should be excluded of such a financial incentive as it defeats the purpose of 
home, i.e., no impact on hospital acquired infections, lower impact on patient’s schedule and 
quality of life.  
Penalties or incentives on outcomes have only been recently implemented in dialysis and 
their impact is yet to be measured. However, there are examples in other fields of medicine, 
e.g., the Centers for Medicare and Medicaid Services and Premier Hospitals Quality 
Incentive Demonstration program on 34 key performance indicators for 5 target diseases 
where a bonus or penalty is given to hospital lying outside of the norm (top and last 2 
deciles); UK Quality Outcomes Framework to increase delivery of chronic care; Centers for 
Medicare and Medicaid Services non-payment for iatrogenic conditions, nosocomial 
infections and other similar complications; UK fine program on methicilin-resistant 
Staphylococcus aureus and Clostridium difficile infections. In their recent paper, Finkelstein et 
al, 2011, suggested a series of 12 quality improvement domains adapted from the Kidney 
Disease Outcomes Quality Initiative recommendations that could represent good targets for 
a dialysis related quality incentive. 
Recommendation 6: Implement a financial incentive (that could be temporary until the target 
is reached) that will reward centres achieving a certain proportion of patients treated at home. 
Recommendation 7: Implement a penalty for poor outcomes such as survival or 
hospitalizations/complications and/or for failing to meet set centre home dialysis targets. 
6.4 Pillar 4 – tracking 
With the exception of the US (great quality registry but low usage of home) and Canada 
(low quality of registry but high usage of home), countries with a high usage of home 
modalities have good renal registries that track not only incidence, prevalence and 
mortality, but also quality indicators, morbidities (such as complications or hospitalizations) 
and changes in survival over time. 
Recommendation 8: Establish a renal registry that will track morbidity (e.g., 
hospitalizations, days in hospitals, infections, complications, etc.) and changes in survival 
over time and use the data to assess impact of renal care policies and to plan future needs 
for renal services and healthcare professional training. 
The recommendations are summarized in Table 4. 
 
 
Framework 
pillar 
Recommendation 
number 
Recommendation 
Home target 1 Set a reasonable proportion of patients (e.g., 10 to 15% 
over the current level up to 35% for PD and 15% home 
HD) that should be treated at home within a set time 
frame (e.g., 5 years). 
Organization 
of renal 
services 
2 Correct provider-driven demand by adjusting 
reimbursement levels to real costs or healthcare system 
value and use similar payment flow for in-centre and 
home modalities. Make healthcare costs more 
transparent by tracking provider costs and making 
them available to public. 
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Framework 
pillar 
Recommendation 
number 
Recommendation 
3 Drive the development of high quality, unbiased, and 
ideally independent pre-dialysis education programs 
by providing adequate reimbursement for this activity. 
4 Facilitate and actively encourage the adoption of home 
dialysis through the provision and reimbursement of 
assisted home dialysis 
5 Establish a holistic approach of dialysis care in an 
overall dialysis care guideline/policy integrating the 
patient “RRT career” concept. 
Incentives 6 Implement a financial incentive (that could be 
temporary until the target is reached) that will reward 
centres achieving a certain proportion of patients 
treated at home. 
7 Implement a penalty for poor outcomes such as 
survival or hospitalizations/complications and/or for 
failing to meet set centre home dialysis targets. 
Tracking 8 Establish a renal registry that will track morbidity (e.g., 
hospitalizations, days in hospitals, infections, 
complications, etc.) and changes in survival over time 
and use the data to plan future needs for renal services 
and healthcare professional training. 
Table 4. Recommendation for change in renal services  
7. Discussion 
The cross-sectional nature of the analysis prevents the identification of a causal relationship 
between the score on the 4-pillar framework and the use of home modalities. The recent 
changes in the US and in the UK will be kept on the radar screen for their impact on home 
modalities. Small (3-5%) upward trends in the usage of home modalities were observed in 
most Nordic countries and Canada from 2004 to 2008, all countries that scored highly on the 
framework. The common themes between these 4 countries are the lack of provider-driven 
demand, well structured pre-dialysis education programs, and clinical guidelines/policies 
favouring home modalities, i.e., the 3 factors identified as significant in the analysis of 
variance. On the other hand, the remarkable decrease in usage of home modalities observed 
in the UK and the Netherlands while these countries are trying to let the market forces play 
a more active role seems to be detrimental to therapies such as home dialysis that generate 
savings outside of the budget scope of the dialysis providers. Provider efficiency may not 
always be compatible with overall healthcare system efficiency. 
With lower income countries such as Hong-Kong, Mexico and Latin America having a high 
usage of peritoneal dialysis and higher income countries having a high usage of 
haemodialysis, it is tempting to conclude that peritoneal dialysis might be an inferior good, 
i.e., one for which the usage is decreasing as income increases (like cheap cars or inter-city 
bus transport). However, our analysis showed that countries such as the Nordics, that have 
an elevated gross domestic product, also have a high usage of home modalities. This is not 
supporting an inferior good status for peritoneal dialysis. 
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It is likely that no single factor is the secret weapon and that any change in the usage of 
home modalities will be the result of the inter-relation of the various factors described by the 
4-pillar framework and maybe other factors not taken into consideration in this analysis 
(Chaudhary et al, 2011, Finkelstein FO et al, 2011). Nevertheless, it is reasonable to think that 
improving the score on the 4-pillar framework, and especially on the 3 factors identified by 
the analysis of variance (i.e., absence of provider-driven demand, well structured pre-
dialysis education programs, clinical guidelines favouring home) would impact on the 
usage of home modalities. 
8. Conclusions 
The analysis of the organization of dialysis services in 14 countries allowed the identification 
of several factors organized in a 4-pillar framework that favour the use of home modalities. 
Furthermore, several avenues for improvement were identified in the course of the analysis 
and have been used to suggest a series of 8 recommendations for change in renal policy and 
reimbursement. Some of these recommendations are in the process of being implemented 
(although secondary to a process totally independent from this analysis) in some countries. 
It will be interesting to assess the impact of the USA quality incentive program, the pre-
dialysis education program and the new reimbursement tariffs on the usage of home 
dialysis in the years to come.  
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